Senior Editor.
[email protected] (Pasco)
Department of Clinical and Biomedical Sciences: Barwon Health, University of Melbourne, Geelong, Australia (Kotowicz) (Henry) (Nicholson)
Alfred Pathology Service, Melbourne, Australia (Spilsbury) (Box)
Department of Medicine, Monash University, Melbourne, Australia (Schneider)
AuthorContributions: Dr Pasco had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Pasco, Kotowicz, Nicholson, Schneider.
Acquisition of data: Pasco, Kotowicz, Henry, Spilsbury, Box, Schneider.
Analysis and interpretation of data: Pasco, Kotowicz, Schneider.
Drafting of the manuscript: Pasco, Kotowicz.
Critical revision of the manuscript for important intellectual content: Pasco, Kotowicz, Henry, Nicholson, Spilsbury, Box, Schneider.
Statistical analysis: Pasco, Henry.
Obtained funding: Pasco, Kotowicz, Nicholson, Schneider.
Administrative, technical, or material support: Pasco, Nicholson, Spilsbury, Box, Schneider.
Study supervision: Pasco, Kotowicz, Nicholson, Schneider.
Financial Disclosures: Dr Schneider reports having applied for an Australian patent, provisional application 2005902311. Dr Schneider and Dr Nicholson have applied for an international patent, application PCT/AU2006/000592. Both patents are for the use of hsCRP to predict fractures. The beneficiaries of the patent income would be Bayside Health and the University of Melbourne. No other financial disclosures were reported.
Funding/Support: The study was funded by the Victorian Health Promotion Foundation and the Geelong Region Medical Research Foundation.
Role of the Sponsors: The sponsors played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.
